SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the C3.ai class action lawsuit – captioned Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.) – seeks to represent purchasers or acquirers of C3.ai, Inc. (NYSE: AI) securities and charges C3.ai and certain of C3.ai’s executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the C3.ai class action lawsuit, please provi ...

Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its growth and the impact of its CEO's health on the company's performance [3][4]. Summary by Sections Allegations - The complaint claims that C3.ai's management provided overly positive statements while concealing material adverse facts about the company's growth, particularly the CEO's health affecting deal closures [3]. - The company announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing this to "the reorganization with new leadership" and the CEO's health issues [3]. Stock Performance - Following the announcement on August 8, 2025, C3.ai's stock price dropped from $22.13 per share to $16.47 per share by August 11, 2025, marking a decline of approximately 25.58% in just one day [3]. Class Action Details - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action, with a deadline of October 21, 2025, to seek lead plaintiff status [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates throughout the case [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5].

Core Viewpoint - A class action lawsuit has been filed against C3.ai and its executives, alleging misleading statements regarding the company's financial health and growth prospects, particularly related to CEO Thomas M. Siebel's health issues [1][2][3]. Summary by Sections Lawsuit Details - The lawsuit, titled Liggett v. C3.ai, Inc., claims that C3.ai provided overly optimistic revenue projections while downplaying risks associated with Siebel's health [2]. - The class period for the lawsuit is from February 26, 2025, to August 8, 2025, with a lead plaintiff deadline set for October 21, 2025 [2][4]. Financial Impact - Following a disappointing financial announcement on August 8, 2025, where C3.ai reported preliminary first-quarter results that did not meet expectations and lowered its revenue guidance, the company's stock price dropped by over 25% [3]. Investigation Focus - The investigation is centered on whether C3.ai's public statements were misleading, particularly regarding the impact of Siebel's health on the company's ability to achieve financial targets [5].

Core Insights - Concerns are rising about a potential AI bubble, drawing parallels to the dot-com bubble of 2000, with significant market reactions observed recently [1][4][5] - Despite fears, investment in AI continues, highlighted by OpenAI's multibillion-dollar deal with AMD, which significantly boosted AMD's stock [1][3] - Reports indicate a troubling trend in the AI sector, including high failure rates of generative AI projects and restructuring efforts at major companies like Meta [2][3] Investment Trends - OpenAI's recent release of ChatGPT-5 received negative feedback, prompting the reinstatement of the previous model for paying customers, indicating challenges in maintaining user satisfaction [3] - The Nasdaq index fell over 3%, and the S&P 500 lost $1 trillion in value amid market fears, reflecting the volatility in tech stocks [1][3] - AI stocks, such as C3.ai, experienced significant declines, with a drop of 28.2% in August, showcasing the market's sensitivity to negative news [1][2] Market Sentiment - Industry leaders, including OpenAI's CEO Sam Altman, acknowledge the existence of a bubble in AI investments, suggesting that investor enthusiasm may be excessive [2][8] - Analysts express that while the AI theme remains strong, there is a saturation point, and the market is vulnerable to rapid shifts in sentiment [7][8] - The current state of the market is described as fragile, with volatility expected as investors navigate the uncertain landscape of AI [10][9]

Core Points - A class action has been filed against C3.ai, Inc. on behalf of investors who acquired its securities between February 26, 2025, and August 8, 2025, due to allegations of misleading information regarding the CEO's health and its impact on business prospects [1][2] - The complaint highlights that C3.ai did not disclose how the CEO's health affected the company's ability to close deals and that management was ineffective in mitigating this impact, leading to concerns about the company's growth and profitability [2] - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health, resulting in a stock price drop of over 25% from $22.13 to $16.47 [3] Legal Proceedings - Shareholders interested in serving as lead plaintiffs must submit their papers to the court by October 21, 2025, with the lead plaintiff representing other class members in the litigation [4] - Shareholders can remain absent class members and are not required to participate in the case to be eligible for recovery [4] Company Background - Robbins LLP, the firm handling the class action, has been focused on shareholder rights litigation since 2002, aiming to help shareholders recover losses and improve corporate governance [5]

Core Viewpoint - Wall Street is concerned about a potential bubble in the artificial intelligence (AI) sector, with analysts divided on the viability of AI investments within the expected timeframe [1] Group 1: Market Sentiment - Goldman Sachs strategist Peter Oppenheimer suggests that fears of a bubble in U.S. tech stocks may be premature, attributing the current rally to strong earnings rather than speculation [2] - Oppenheimer notes that while valuations are stretched, they are not yet at levels consistent with historical bubbles, with the Nasdaq 100 trading at 28x forward earnings compared to its 10-year average of 23 [2] - Some experts, like Santa Clara University's Ram Bala, believe that AI investments will yield long-term returns, while AMD CEO Lisa Su views the AI boom as the start of a 10-year super-cycle [6] Group 2: AI Investment Landscape - OpenAI, valued at $500 billion, has not yet demonstrated a profitable business model despite significant investments in data centers and partnerships with NVIDIA, AMD, and Oracle [4] - Major tech companies, including NVIDIA, Oracle, Amazon, Google, Meta, and Microsoft, are making substantial investments in AI, indicating a bullish outlook despite concerns about a bubble [4][7] - Jeff Bezos and Goldman Sachs CEO David Solomon express caution, warning that rapid capital formation may outpace actual potential [5] Group 3: Financial Metrics of Big Tech - Big tech companies are characterized by strong cash positions, with Alphabet's cash flow/share at 9.47X, Amazon at 10.57X, Microsoft at 18.29X, and Meta at 30.73X, compared to the S&P 500 average of 8.99X [9] - The debt/equity ratios for Alphabet and Tesla are 0.07X, significantly lower than the S&P 500 average of 0.58X, indicating a strong balance sheet position for these companies [10][11] - The overall financial health of these companies suggests they are well-positioned to navigate potential market volatility [11] Group 4: Investment Vehicles - Investors may consider exchange-traded funds (ETFs) to gain exposure to Big Tech, with notable ETFs including Roundhill Magnificent Seven ETF (MAGS) up 5.6% in the past month, MicroSectors FANG+ ETN (FNGS) up 2.4%, and Vanguard Mega Cap Growth ETF (MGK) up 4.7% [12]

LOS ANGELES, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises C3.ai, Inc., (“C3” or the "Company") (NASDAQ: AI) investors of a class action on behalf of investors that bought securities between February 26, 2025 and August 8, 2025, inclusive (the “Class Period”). C3 investors have until October 21, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join th ...

Market Overview - The U.S. stock market is experiencing a significant rally, with major indices reaching new highs, primarily driven by the growth of artificial intelligence (AI) and tech stocks [1] - Analysts and economists express concerns that this rally may be a speculative bubble, indicating a potential market correction in the near future [3][4] Defensive Sector ETFs - Investors may shift their focus towards Exchange-Traded Funds (ETFs), particularly defensive sector ETFs, which have historically provided protection against losses during economic downturns [2] - Defensive sector ETFs are seen as a safe harbor during periods of market turbulence, with sectors like consumer staples, utilities, and healthcare being favored for their stability [7] Consumer Staples ETFs - Consumer staples ETFs offer exposure to essential goods companies, which are less sensitive to economic cycles [8] - Notable consumer staples ETFs include Consumer Staples Select Sector SPDR Fund (XLP), Vanguard Consumer Staples ETF (VDC), and iShares Global Consumer Staples ETF (KXI) [8] - XLP is highlighted as the cheapest option, with fees of 8 basis points and assets under management (AUM) of $15.7 million [9] Utility ETFs - Utility ETFs are characterized by steady demand and relative protection from trade and policy disruptions [10] - Key utility ETFs to consider include Utilities Select Sector SPDR ETF (XLU), iShares U.S. Utilities ETF (IDU), and Vanguard Utilities ETF (VPU) [10] - XLU is noted as the most cost-effective option, charging 8 basis points in fees and having AUM of $21.9 million [11] Healthcare ETFs - The healthcare sector is resilient due to the ongoing demand for medical services and innovations [12] - Prominent healthcare ETFs include iShares Global Healthcare ETF (IXJ), Vanguard Health Care ETF (VHT), and Health Care Select Sector SPDR Fund (XLV) [12] - XLV is identified as the cheapest option, with fees of 8 basis points and AUM of $36.1 million [12] Market Valuation Concerns - The Shiller P/E ratio is currently at 46.2%, significantly above the 20-year average of 27.2, indicating that the market may be overvalued and future returns could be limited [5] - The concentration of investments in a few tech giants raises concerns about fragility in the market, as small earnings setbacks could lead to sharp declines [6]

Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of providing misleading statements about its growth and the impact of its CEO's health on the company's performance, leading to a significant drop in stock price following disappointing financial results [1][2]. Summary by Sections Allegations - The complaint claims that C3.ai's management made overly positive statements while concealing material adverse facts about the company's growth, particularly regarding the CEO's health affecting deal closures and overall performance [1]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health problems [1]. Stock Price Impact - Following the announcement of poor financial results, C3.ai's stock price fell from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [1]. Class Action Details - Shareholders who purchased shares during the specified class period (February 26, 2025, to August 8, 2025) are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for October 21, 2025 [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case, with no cost or obligation to participate [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud, aiming to ensure companies adhere to responsible business practices [3].

, /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against C3.ai, Inc. (NYSE: AI) ("C3.ai" or the "Company") on behalf of investors who purchased or acquired shares during the period from February 26, 2025 through August 8, 2025 (the "Class Period"), Investor Deadline: Investors who purchased or acquired C3.ai securities during the Class Period may, no later than October 21, 2025, seek to be appointed as a lead plaintiff representative of the class. To lea ...